Pharmaco-transcranial magnetic stimulation studies of motor excitability

Handbook of Clinical Neurology

Volumn 116, Issue , 2013, Pages 387-397

  Ziemann, Ulf ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

CNS active drugs; Excitability; Intracortical facilitation; Intracortical inhibition; Motor cortex; Motor evoked potential; Motor threshold; Pharmaco TMS; Transcranial magnetic stimulation (TMS)

Indexed keywords

CENTRAL NERVOUS SYSTEM AGENTS;

ANIMAL; ARTICLE; CNS ACTIVE DRUGS; DRUG EFFECT; EVOKED MUSCLE RESPONSE; EXCITABILITY; HUMAN; INTRACORTICAL FACILITATION; INTRACORTICAL INHIBITION; MOTOR CORTEX; MOTOR THRESHOLD; PHARMACO-TMS; PHYSIOLOGY; REACTION TIME; TRANSCRANIAL MAGNETIC STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION (TMS);

CNS ACTIVE DRUGS; EXCITABILITY; INTRACORTICAL FACILITATION; INTRACORTICAL INHIBITION; MOTOR CORTEX; MOTOR EVOKED POTENTIAL; MOTOR THRESHOLD; PHARMACO-TMS; TRANSCRANIAL MAGNETIC STIMULATION (TMS);

ANIMALS; CENTRAL NERVOUS SYSTEM AGENTS; EVOKED POTENTIALS, MOTOR; HUMANS; MOTOR CORTEX; REACTION TIME; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 84885171048     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-53497-2.00032-2     Document Type: Chapter

References (138)

1. Amassian V.E., Stewart M., Quirk G.J., et al. Physiological basis of motor effects of a transient stimulus to cerebral cortex. Neurosurgery 1987, 20:74-93.
2. Awiszus F. TMS and threshold hunting. Suppl Clin Neurophysiol 2003, 56:13-23.
3. Awiszus F., Feistner H., Urbach D., et al. Characterisation of paired-pulse transcranial magnetic stimulation conditions yielding inhibition or I-wave facilitation using a threshold-hunting paradigm. Exp Brain Res 1999, 129:317-324.
4. Beauregard M., Ferron A. Dopamine modulates the inhibition induced by GABA in rat cerebral cortex: an iontophoretic study. Eur J Pharmacol 1991, 205:225-231.
5. Benwell N.M., Mastaglia F.L., Thickbroom G.W. Differential changes in long-interval intracortical inhibition and silent period duration during fatiguing hand exercise. Exp Brain Res 2007, 179:255-262.
6. Boroojerdi B., Battaglia F., Muellbacher W., et al. Mechanisms influencing stimulus-response properties of the human corticospinal system. Clin Neurophysiol 2001, 112:931-937.
7. Brasil-Neto J.P., Cammarota A., Valls-Sole J., et al. Role of intracortical mechanisms in the late part of the silent period to transcranial stimulation of the human motor cortex. Acta Neurol Scand 1995, 92:383-386.
8. Cantello R., Gianelli M., Civardi C., et al. Magnetic brain stimulation: the silent period after the motor evoked potential. Neurology 1992, 42:1951-1959.
9. Cantello R., Tarletti R., Civardi C. Transcranial magnetic stimulation and Parkinson's disease. Brain Res Brain Res Rev 2002, 38:309-327.
10. Chen R., Garg R. Facilitatory I wave interaction in proximal arm and lower limb muscle representations of the human motor cortex. J Neurophysiol 2000, 83:1426-1434.
11. Chen R., Samii A., Canos M., et al. Effects of phenytoin on cortical excitability in humans. Neurology 1997, 49:881-883.
12. Chen R., Tam A., Bütefisch C., et al. Intracortical inhibition and facilitation in different representations of the human motor cortex. J Neurophysiol 1998, 80:2870-2881.
13. Chen R., Lozano A.M., Ashby P. Mechanism of the silent period following transcranial magnetic stimulation. Exp Brain Res 1999, 128:539-542.
14. Chen R., Cros D., Curra A., et al. The clinical diagnostic utility of transcranial magnetic stimulation: report of an IFCN committee. Clin Neurophysiol 2008, 119:504-532.
15. Classen J., Schnitzler A., Binkofski F., et al. The motor syndrome associated with exaggerated inhibition within the primary motor cortex of patients with hemiparetic stroke. Brain 1997, 120:605-619.
16. Claus D., Weis M., Jahnke U., et al. Corticospinal conduction studied with magnetic double stimulation in the intact human. J Neurol Sci 1992, 111:180-188.
17. B receptor-mediated responses in neocortex of rat and cat. J Physiol (Lond) 1988, 406:443-468.
18. Curra A., Modugno N., Inghilleri M., et al. Transcranial magnetic stimulation techniques in clinical investigation. Neurology 2002, 59:1851-1859.
19. Deguchi Y., Inabe K., Tomiyasu K., et al. Study on brain interstitial fluid distribution and blood-brain barrier transport of baclofen in rats by microdialysis. Pharm Res 1995, 12:1838-1844.
20. Deisz R.A. GABA(B) receptor-mediated effects in human and rat neocortical neurones in vitro. Neuropharmacology 1999, 38:1755-1766.
21. Devanne H., Lavoie B.A., Capaday C. Input-output properties and gain changes in the human corticospinal pathway. Exp Brain Res 1997, 114:329-338.
22. Di Lazzaro V., Rothwell J.C., Oliviero A., et al. Intracortical origin of the short latency facilitation produced by pairs of threshold magnetic stimuli applied to human motor cortex. Exp Brain Res 1999, 129:494-499.
23. Di Lazzaro V., Oliviero A., Meglio M., et al. Direct demonstration of the effect of lorazepam on the excitability of the human motor cortex. Clin Neurophysiol 2000, 111:794-799.
24. Di Lazzaro V., Oliviero A., Profice P., et al. Muscarinic receptor blockade has differential effects on the excitability of intracortical circuits in human motor cortex. Exp Brain Res 2000, 135:455-461.
25. Di Lazzaro V., Oliviero A., Mazzone P., et al. Direct demonstration of long latency cortico-cortical inhibition in normal subjects and in a patient with vascular parkinsonism. Clin Neurophysiol 2002, 113:1673-1679.
26. Di Lazzaro V., Oliviero A., Tonali P.A., et al. Noninvasive in vivo assessment of cholinergic cortical circuits in AD using transcranial magnetic stimulation. Neurology 2002, 59:392-397.
27. Di Lazzaro V., Oliviero A., Profice P., et al. Ketamine increases motor cortex excitability to transcranial magnetic stimulation. J Physiol 2003, 547:485-496.
28. Di Lazzaro V., Oliviero A., Pilato F., et al. Motor cortex hyperexcitability to transcranial magnetic stimulation in Alzheimer's disease. J Neurol Neurosurg Psychiatry 2004, 75:555-559.
29. Di Lazzaro V., Oliviero A., Pilato F., et al. Neurophysiological predictors of long term response to AChE inhibitors in AD patients. J Neurol Neurosurg Psychiatry 2005, 76:1064-1069.
30. Di Lazzaro V., Oliviero A., Saturno E., et al. Effects of lorazepam on short latency afferent inhibition and short latency intracortical inhibition in humans. J Physiol 2005, 564:661-668.
31. Di Lazzaro V., Pilato F., Dileone M., et al. Dissociated effects of diazepam and lorazepam on short latency afferent inhibition. J Physiol 2005, 569:315-323.
32. A receptor subtype specific enhancement of inhibition in human motor cortex. J Physiol 2006, 575:721-726.
33. Di Lazzaro V., Pilato F., Oliviero A., et al. Origin of facilitation of motor-evoked potentials after paired magnetic stimulation: direct recording of epidural activity in conscious humans. J Neurophysiol 2006, 96:1765-1771.
34. A receptor subtypes: a TMS study. Clin Neurophysiol 2007, 118:2207-2214.
35. Di Lazzaro V., Ziemann U., Lemon R.N. State of the art: physiology of transcranial motor cortex stimulation. Brain Stimul 2008, 1:345-362.
36. Douglas R., Martin K. Neocortex. The Synaptic Organization of the Brain 1998, 459-509. Oxford University Press, New York. G.M. Shepherd (Ed.).
37. Eichhammer P., Langguth B., Wiegand R., et al. Allelic variation in the serotonin transporter promoter affects neuromodulatory effects of a selective serotonin transporter reuptake inhibitor (SSRI). Psychopharmacology (Berl) 2003, 166:294-297.
38. Fischer M., Orth M. Short-latency sensory afferent inhibition: conditioning stimulus intensity, recording site, and effects of 1Hz repetitive TMS. Brain Stimul 2011, 4:202-209.
39. Fisher R.J., Nakamura Y., Bestmann S., et al. Two phases of intracortical inhibition revealed by transcranial magnetic threshold tracking. Exp Brain Res 2002, 143:240-248.
40. Freitas C., Mondragon-Llorca H., Pascual-Leone A. Noninvasive brain stimulation in Alzheimer's disease: systematic review and perspectives for the future. Exp Gerontol 2011, 46:611-627.
41. Fuhr P., Agostino R., Hallett M. Spinal motor neuron excitability during the silent period after cortical stimulation. Electroencephalogr Clin Neurophysiol 1991, 81:257-262.
42. Gerdelat-Mas A., Loubinoux I., Tombari D., et al. Chronic administration of selective serotonin reuptake inhibitor (SSRI) paroxetine modulates human motor cortex excitability in healthy subjects. Neuroimage 2005, 27:314-322.
43. Gilbert D.L., Ridel K.R., Sallee F.R., et al. Comparison of the inhibitory and excitatory effects of ADHD medications methylphenidate and atomoxetine on motor cortex. Neuropsychopharmacology 2006, 31:442-449.
44. Hallett M. Transcranial magnetic stimulation: a primer. Neuron 2007, 55:187-199.
45. Hammond G., Vallence A.M. Modulation of long-interval intracortical inhibition and the silent period by voluntary contraction. Brain Res 2007, 1158:63-70.
46. Hanajima R., Ugawa Y., Terao Y., et al. Paired-pulse magnetic stimulation of the human motor cortex: differences among I waves. J Physiol 1998, 509:607-618.
47. Hanajima R., Ugawa Y., Terao Y., et al. Mechanisms of intracortical I-wave facilitation elicited with paired-pulse magnetic stimulation in humans. J Physiol 2002, 538:253-261.
48. Hanajima R., Furubayashi T., Iwata N.K., et al. Further evidence to support different mechanisms underlying intracortical inhibition of the motor cortex. Exp Brain Res 2003, 151:427-434.
49. Hasselmo M.E. Neuromodulation and cortical function: modeling the physiological basis of behavior. Behav Brain Res 1995, 67:1-27.
50. Heidegger T., Krakow K., Ziemann U. Effects of antiepileptic drugs on associative LTP-like plasticity in human motor cortex. Eur J Neurosci 2010, 32:1215-1222.
51. Herwig U., Bräuer K., Connemann B., et al. Intracortical excitability is modulated by a norepinephrine-reuptake inhibitor as measured with paired-pulse transcranial magnetic stimulation. Psychopharmacology 2002, 164:228-232.
52. Hess C.W., Mills K.R., Murray N.M. Responses in small hand muscles from magnetic stimulation of the human brain. J Physiol 1987, 388:397-419.
53. Hodgkin A.L., Huxley A.F. A quantitative description of membrane current and its application to conduction and excitation in nerve. J Physiol (Lond) 1952, 116:500-544.
54. Hoshiyama M., Kakigi R. Shortening of the cortical silent period following transcranial magnetic brain stimulation during an experimental paradigm for generating contingent negative variation (CNV). Clin Neurophysiol 1999, 110:1394-1398.
55. Hufnagel A., Elger C.E., Marx W., et al. Magnetic motor-evoked potentials in epilepsy: effects of the disease and of anticonvulsant medication. Ann Neurol 1990, 28:680-686.
56. B-mediated inhibition in thalamic relay neurons through effects in nucleus reticularis. J Neurophysiol 1994, 71:2576-2581.
57. Hwa G.G., Avoli M. Excitatory postsynaptic potentials recorded from regular-spiking cells in layers II/III of rat sensorimotor cortex. J Neurophysiol 1992, 67:728-737.
58. Ilić T.V., Korchounov A., Ziemann U. Complex modulation of human motor cortex excitability by the specific serotonin re-uptake inhibitor sertraline. Neurosci Lett 2002, 319:116-120.
59. Ilić T.V., Meintzschel F., Cleff U., et al. Short-interval paired-pulse inhibition and facilitation of human motor cortex: the dimension of stimulus intensity. J Physiol 2002, 545:153-167.
60. Ilić T.V., Korchounov A., Ziemann U. Methylphenidate facilitates and disinhibits the motor cortex in intact humans. Neuroreport 2003, 14:773-776.
61. Inghilleri M., Berardelli A., Cruccu G., et al. Silent period evoked by transcranial stimulation of the human cortex and cervicomedullary junction. J Physiol (Lond) 1993, 466:521-534.
62. Inghilleri M., Berardelli A., Marchetti P., et al. Effects of diazepam, baclofen and thiopental on the silent period evoked by transcranial magnetic stimulation in humans. Exp Brain Res 1996, 109:467-472.
63. Jung H.Y., Sohn Y.H., Mason A., et al. Flumazenil does not affect intracortical motor excitability in humans: a transcranial magnetic stimulation study. Clin Neurophysiol 2004, 115:325-329.
64. Kawaguchi Y., Kondo S. Parvalbumin, somatostatin and cholecystokinin as chemical markers for specific GABAergic interneuron types in the rat frontal cortex. J Neurocytol 2002, 31:277-287.
65. Kimiskidis V.K., Papagiannopoulos S., Sotirakoglou K., et al. Silent period to transcranial magnetic stimulation: construction and properties of stimulus-response curves in healthy volunteers. Exp Brain Res 2005, 163:21-31.
66. Kimiskidis V.K., Papagiannopoulos S., Kazis D.A., et al. Lorazepam-induced effects on silent period and corticomotor excitability. Exp Brain Res 2006, 173:603-611.
67. Kirschner J., Moll G.H., Fietzek U.M., et al. Methylphenidate enhances both intracortical inhibition and facilitation in healthy adults. Pharmacopsychiatry 2003, 36:79-82.
68. Korchounov A., Ilić T.V., Ziemann U. TMS-assisted neurophysiological profiling of the dopamine receptor agonist cabergoline in human motor cortex. J Neural Transm 2007, 114:223-229.
69. Kujirai T., Caramia M.D., Rothwell J.C., et al. Corticocortical inhibition in human motor cortex. J Physiol (Lond) 1993, 471:501-519.
70. Lang N., Hasan A., Sueske E., et al. Cortical hypoexcitability in chronic smokers? A transcranial magnetic stimulation study. Neuropsychopharmacology 2008, 33:2517-2523.
71. Li X., Teneback C.C., Nahas Z., et al. Interleaved transcranial magnetic stimulation/functional MRI confirms that lamotrigine inhibits cortical excitability in healthy young men. Neuropsychopharmacology 2004, 29:1395-1407.
72. Markram H., Toledo-Rodriguez M., Wang Y., et al. Interneurons of the neocortical inhibitory system. Nat Rev Neurosci 2004, 5:793-807.
73. Mathis J., de Quervain D., Hess C.W. Dependence of the transcranially induced silent period on the 'instruction set' and the individual reaction time. Electroencephalogr Clin Neurophysiol 1998, 109:426-435.
74. Mathis J., de Quervain D., Hess C.W. Task-dependent effects on motor-evoked potentials and on the following silent period. J Clin Neurophysiol 1999, 16:556-565.
75. Mavroudakis N., Caroyer J.M., Brunko E., et al. Effects of diphenylhydantoin on motor potentials evoked with magnetic stimulation. Electroencephalogr Clin Neurophysiol 1994, 93:428-433.
76. McDonnell M.N., Orekhov Y., Ziemann U. The role of GABA(B) receptors in intracortical inhibition in the human motor cortex. Exp Brain Res 2006, 173:86-93.
77. Mohammadi B., Krampfl K., Petri S., et al. Selective and nonselective benzodiazepine agonists have different effects on motor cortex excitability. Muscle Nerve 2006, 33:778-784.
78. Möhler H. GABA(A) receptor diversity and pharmacology. Cell Tissue Res 2006, 326:505-516.
79. Moll G.H., Heinrich H., Wischer S., et al. Motor system excitability in healthy children: developmental aspects from transcranial magnetic stimulation. Electroencephalogr Clin Neurophysiol Suppl 1999, 51:243-249.
80. Moll G.H., Heinrich H., Rothenberger A. Methylphenidate and intracortical excitability: opposite effects in healthy subjects and attention-deficit hyperactivity disorder. Acta Psychiatr Scand 2003, 107:69-72.
81. Möller C., Arai N., Lücke J., et al. Hysteresis effects on the input-output curve of motor evoked potentials. Clin Neurophysiol 2009, 120:1003-1008.
82. Müller-Dahlhaus J.F., Liu Y., Ziemann U. Inhibitory circuits and the nature of their interactions in the human motor cortex: a pharmacological TMS study. J Physiol 2008, 586:495-514.
83. Nakamura H., Kitagawa H., Kawaguchi Y., et al. Intracortical facilitation and inhibition after transcranial magnetic stimulation in conscious humans. J Physiol (Lond) 1997, 498:817-823.
84. Nardone R., Bergmann J., Kronbichler M., et al. Abnormal short latency afferent inhibition in early Alzheimer's disease: a transcranial magnetic demonstration. J Neural Transm 2008, 115:1557-1562.
85. Nardone R., De Blasi P., Seidl M., et al. Cognitive function and cholinergic transmission in patients with subcortical vascular dementia and microbleeds: a TMS study. J Neural Transm 2011, 118:1349-1358.
86. Ni Z., Müller-Dahlhaus F., Chen R., et al. Triple-pulse TMS to study interactions between neural circuits in human cortex. Brain Stimul 2011, 4:281-293.
87. Oliviero A., Profice P., Tonali P.A., et al. Effects of aging on motor cortex excitability. Neurosci Res 2006, 55:74-77.
88. Orth M., Amann B., Ratnaraj N., et al. Caffeine has no effect on measures of cortical excitability. Clin Neurophysiol 2005, 116:308-314.
89. Patton H.D., Amassian V.E. Single- and multiple-unit analysis of cortical stage of pyramidal tract activation. J Neurophysiol 1954, 17:345-363.
90. Paulus W., Classen J., Cohen L.G., et al. State of the art: pharmacologic effects on cortical excitability measures tested by transcranial magnetic stimulation. Brain Stimul 2008, 1:151-163.
91. Peinemann A., Lehner C., Conrad B., et al. Age-related decrease in paired-pulse intracortical inhibition in the human primary motor cortex. Neurosci Lett 2001, 313:33-36.
92. Peurala S.H., Müller-Dahlhaus J.F.M., Arai N., et al. Interference of short-interval intracortical inhibition (SICI) and short-interval intracortical facilitation (SICF). Clin Neurophysiol 2008, 119:2291-2297.
93. Pierantozzi M., Marciani M.G., Palmieri M.G., et al. Effect of vigabatrin on motor responses to transcranial magnetic stimulation: an effective tool to investigate in vivo GABAergic cortical inhibition in humans. Brain Res 2004, 1028:1-8.
94. Pitcher J.B., Ogston K.M., Miles T.S. Age and sex differences in human motor cortex input-output characteristics. J Physiol 2003, 546:605-613.
95. Plewnia C., Bartels M., Cohen L., et al. Noradrenergic modulation of human cortex excitability by the presynaptic alpha(2)-antagonist yohimbine. Neurosci Lett 2001, 307:41-44.
96. Plewnia C., Hoppe J., Hiemke C., et al. Enhancement of human cortico-motoneuronal excitability by the selective norepinephrine reuptake inhibitor reboxetine. Neurosci Lett 2002, 330:231-234.
97. Plewnia C., Hoppe J., Cohen L.G., et al. Improved motor skill acquisition after selective stimulation of central norepinephrine. Neurology 2004, 62:2124-2126.
98. Priori A., Berardelli A., Inghilleri M., et al. Motor cortical inhibition and the dopaminergic system. Pharmacological changes in the silent period after transcranial brain stimulation in normal subjects, patients with Parkinson's disease and drug-induced parkinsonism. Brain 1994, 117:317-323.
99. Qi F., Wu A.D., Schweighofer N. Fast estimation of transcranial magnetic stimulation motor threshold. Brain Stimul 2011, 4:50-57.
100. Ridding M.C., Ziemann U. Determinants of the induction of cortical plasticity by non-invasive brain stimulation inn healthy subjects. J Physiol 2010, 588:2291-2304.
101. Ridding M.C., Taylor J.L., Rothwell J.C. The effect of voluntary contraction on cortico-cortical inhibition in human motor cortex. J Physiol (Lond) 1995, 487:541-548.
102. Rossi S., Hallett M., Rossini P.M., et al. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol 2009, 120:2008-2039.
103. Rossini P.M., Berardelli A., Deuschl G., et al. Applications of magnetic cortical stimulation. Electroencephalogr Clin Neurophysiol Suppl 1999, 52:171-185.
104. Sanger T.D., Garg R.R., Chen R. Interactions between two different inhibitory systems in the human motor cortex. J Physiol 2001, 530:307-317.
105. Schäfer M., Biesecker J.C., Schulze-Bonhage A., et al. Transcranial magnetic double stimulation: influence of the intensity of the conditioning stimulus. Electroencephalogr Clin Neurophysiol 1997, 105:462-469.
106. Schönle P.W., Isenberg C., Crozier T.A., et al. Changes of transcranially evoked motor responses in man by midazolam, a short acting benzodiazepine. Neurosci Lett 1989, 101:321-324.
107. Schwenkreis P., Witscher K., Janssen F., et al. Influence of the N-methyl-D-aspartate antagonist memantine on human motor cortex excitability. Neurosci Lett 1999, 270:137-140.
108. Schwenkreis P., Liepert J., Witscher K., et al. Riluzole suppresses motor cortex facilitation in correlation to its plasma level. Exp Brain Res 2000, 135:293-299.
109. Siebner H.R., Dressnandt J., Auer C., et al. Continuous intrathecal baclofen infusions induced a marked increase of the transcranially evoked silent period in a patient with generalized dystonia. Muscle Nerve 1998, 21:1209-1212.
110. Silbert L.C., Nelson C., Holman S., et al. Cortical excitability and age-related volumetric MRI changes. Clin Neurophysiol 2006, 117:1029-1036.
111. Smith M.J., Keel J.C., Greenberg B.D., et al. Menstrual cycle effects on cortical excitability. Neurology 1999, 53:2069-2072.
112. Teo J.T., Terranova C., Swayne O., et al. Differing effects of intracortical circuits on plasticity. Exp Brain Res 2009, 193:555-563.
113. Tergau F., Becher V., Canelo M., et al. Complete suppression of voluntary motor drive during the silent period after transcranial magnetic stimulation. Exp Brain Res 1999, 124:447-454.
114. Tergau F., Wischer S., Somal H.S., et al. Relationship between lamotrigine oral dose, serum level and its inhibitory effect on CNS: insights from transcranial magnetic stimulation. Epilepsy Res 2003, 56:67-77.
115. Tokimura H., Ridding M.C., Tokimura Y., et al. Short latency facilitation between pairs of threshold magnetic stimuli applied to human motor cortex. Electroencephalogr Clin Neurophysiol 1996, 101:263-272.
116. Tokimura H., Di Lazzaro V., Tokimura Y., et al. Short latency inhibition of human hand motor cortex by somatosensory input from the hand. J Physiol 2000, 523:503-513.
117. Valls-Sole J., Pascual-Leone A., Wassermann E.M., et al. Human motor evoked responses to paired transcranial magnetic stimuli. Electroencephalogr Clin Neurophysiol 1992, 85:355-364.
118. Vucic S., Howells J., Trevillion L., et al. Assessment of cortical excitability using threshold tracking techniques. Muscle Nerve 2006, 33:477-486.
119. 2+ channels: a single molecular switch for long-term potentiation/long-term depression-like plasticity and activity-dependent metaplasticity in humans. J Neurosci 2010, 30:6197-6204.
120. Wassermann E.M. Variation in the response to transcranial magnetic brain stimulation in the general population. Clin Neurophysiol 2002, 113:1165-1171.
121. Wassermann E.M., Greenberg B.D., Nguyen M.B., et al. Motor cortex excitability correlates with an anxiety-related personality trait. Biol Psychiatry 2001, 50:377-382.
122. Werhahn K.J., Kunesch E., Noachtar S., et al. Differential effects on motorcortical inhibition induced by blockade of GABA uptake in humans. J Physiol 1999, 517:591-597.
123. Young-Bernier M., Davidson P.S., Tremblay F. Paired-pulse afferent modulation of TMS responses reveals a selective decrease in short latency afferent inhibition with age. Neurobiol Aging 2012, 33:835.e1-835.e11.
124. Ziemann U. Intracortical inhibition and facilitation in the conventional paired TMS paradigm. Electroencephalogr Clin Neurophysiol Suppl 1999, 51:127-136.
125. Ziemann U. TMS and drugs. Clin Neurophysiol 2004, 115:1717-1729.
126. Ziemann U. Transcranial magnetic stimulation at the interface with other techniques: a powerful tool for studying the human cortex. Neuroscientist 2011, 17:368-381.
127. Ziemann U., Hallett M. Basic neurophysiological studies with transcranial magnetic stimulation. Transcranial Magnetic Stimulation in Clinical Psychiatry 2007, 59-84. American Psychiatric Press, Washington, DC. M.S. George, R.H. Belmaker (Eds.).
128. Ziemann U., Rothwell J.C. I-waves in motor cortex. J Clin Neurophysiol 2000, 17:397-405.
129. Ziemann U., Netz J., Szelenyi A., et al. Spinal and supraspinal mechanisms contribute to the silent period in the contracting soleus muscle after transcranial magnetic stimulation of human motor cortex. Neurosci Lett 1993, 156:167-171.
130. Ziemann U., Lönnecker S., Paulus W. Inhibition of human motor cortex by ethanol A transcranial magnetic stimulation study. Brain 1995, 118:1437-1446.
131. Ziemann U., Bruns D., Paulus W. Enhancement of human motor cortex inhibition by the dopamine receptor agonist pergolide: evidence from transcranial magnetic stimulation. Neurosci Lett 1996, 208:187-190.
132. Ziemann U., Lönnecker S., Steinhoff B.J., et al. The effect of lorazepam on the motor cortical excitability in man. Exp Brain Res 1996, 109:127-135.
133. Ziemann U., Lönnecker S., Steinhoff B.J., et al. Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study. Ann Neurol 1996, 40:367-378.
134. Ziemann U., Rothwell J.C., Ridding M.C. Interaction between intracortical inhibition and facilitation in human motor cortex. J Physiol 1996, 496:873-881.
135. Ziemann U., Tergau F., Bruns D., et al. Changes in human motor cortex excitability induced by dopaminergic and anti-dopaminergic drugs. Electroencephalogr Clin Neurophysiol 1997, 105:430-437.
136. Ziemann U., Chen R., Cohen L.G., et al. Dextromethorphan decreases the excitability of the human motor cortex. Neurology 1998, 51:1320-1324.
137. Ziemann U., Tergau F., Wassermann E.M., et al. Demonstration of facilitatory I-wave interaction in the human motor cortex by paired transcranial magnetic stimulation. J Physiol 1998, 511:181-190.
138. Ziemann U., Tergau F., Wischer S., et al. Pharmacological control of facilitatory I-wave interaction in the human motor cortex. A paired transcranial magnetic stimulation study. Electroencephalogr Clin Neurophysiol 1998, 109:321-330.